Concepedia

Rui Suzuki

RS

Statistics

Publications

9

Citations

190

H-Index

9

Active since

2017

Affiliations

Hiroshima University(Current)

Chiba University

Rui Suzuki is an author at Hiroshima University specializing in radiation oncology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2017–2024

9

Publications

9

miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma

Rui Suzuki, Vishwa Jeet Amatya, Kei Kushitani et al. · Frontiers in Oncology · 2018 · 51 citations · Full text

Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma

Vishwa Jeet Amatya, Kei Kushitani, Yuichiro Kai et al. · Modern Pathology · 2018 · 32 citations

, , +8

Enhanced oxygen reduction reaction on caffeine-modified platinum single-crystal electrodes

Nagahiro Hoshi, Masashi Nakamura, Ryuta Kubo et al. · Communications Chemistry · 2024 · 23 citations · Full text

SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma

Takahiro Kambara, Vishwa Jeet Amatya, Kei Kushitani et al. · The American Journal of Surgical Pathology · 2020 · 20 citations

Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma

Yuichiro Kai, Vishwa Jeet Amatya, Kei Kushitani et al. · Histopathology · 2018 · 19 citations

1–5 of 9